Nanomanufacturing with DNA Origami: Factors Affecting the Kinetics and Yield of Quantum Dot Binding
Source abstract
Abstract
Abstract Molecularly directed self‐assembly has the potential to become a nanomanufacturing technology if the critical factors governing the kinetics and yield of defect‐free self‐assembled structures can be understood and controlled. The kinetics of streptavidin‐functionalized quantum dots binding to biontinylated DNA origami are quantitatively evaluated and to what extent the reaction rate and binding efficiency are controlled by the valency of the binding location, the biotin linker length, and the organization, and spacing of the binding locations on the DNA is shown. Yield improvement is systematically determined as a function of the valency of the binding locations and as a function of the quantum dot spacing. In addition, the kinetic studies show that the binding rate increases with increasing linker length, but that the yield saturates at the same level for long incubation times. The forward and backward reaction rate coefficients are determined using a nonlinear least squares fit to the measured binding kinetics, providing considerable physical insight into the factors governing this type of self‐assembly process. It is found that the value of the dissociation constant, Kd, for the DNA–nanoparticle complex considered here is up to seven orders of magnitude larger than that of the native biotin–streptavidin complex. This difference is attributed to the combined effect that the much larger size of the DNA origami and the quantum dot have on the translational and rotational diffusion constants.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Plasmonic and Surface Plasmon Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. 10.1007/s12033-007-0059-410.1007/s12033-007-0059-4 ↗
2. 10.1016/S1748-0132(07)70056-710.1016/S1748-0132(07)70056-7 ↗
3. 10.1002/ejic.20050042510.1002/ejic.200500425 ↗
4. 10.1038/nature0458610.1038/nature04586 ↗
5. 10.1073/pnas.080873610610.1073/pnas.0808736106 ↗
6. 10.1002/anie.20100591110.1002/anie.201005911 ↗
7. 10.1002/chem.20090305710.1002/chem.200903057 ↗
8. 10.1038/nnano.2009.22010.1038/nnano.2009.220 ↗
9. 10.1021/ja802853r10.1021/ja802853r ↗
10. 10.1002/anie.20090331910.1002/anie.200903319 ↗
11. 10.1038/nnano.2009.45010.1038/nnano.2009.450 ↗
12. 10.1002/anie.20100033010.1002/anie.201000330 ↗
13. 10.1021/ja910119810.1021/ja9101198 ↗
14. 10.1021/nl101079u10.1021/nl101079u ↗
15. 10.1038/nnano.2008.16410.1038/nnano.2008.164 ↗
16. 10.1021/nl103307310.1021/nl1033073 ↗
17. 10.1126/science.291172210.1126/science.2911722 ↗
18. 10.1021/ja00148a00310.1021/ja00148a003 ↗
19. 10.1021/bi00037a01210.1021/bi00037a012 ↗
20. 10.1016/S0021-9258(19)39777-710.1016/S0021-9258(19)39777-7 ↗
21. 10.1021/bi00063a02210.1021/bi00063a022 ↗
22. The full description of the procedures used in this paper requires the identification of certain commercial products and their suppliers. The inclusion of such information should in no way be construed as indicating that such products or suppliers are endorsed by NIST or are recommended by NIST or that they are necessarily the best materials instruments or suppliers for the purposes described.
23. Qdot Streptavidin Conjugates Molecular Probes Inc.2007 1.
24. 10.1002/(SICI)1097-0320(19990901)37:1<21::AID-CYTO3>3.0.CO;2-G10.1002/(SICI)1097-0320(19990901)37:1<21::AID-CYTO3>3.0.CO;2-G ↗
25. 10.1016/j.jchromb.2009.08.05010.1016/j.jchromb.2009.08.050 ↗
26. 10.1016/0021-9797(89)90271-310.1016/0021-9797(89)90271-3 ↗
27. 10.1186/1477-3155-6-410.1186/1477-3155-6-4 ↗
28. 10.1021/jp983842h10.1021/jp983842h ↗
29. 10.1006/abio.1996.020810.1006/abio.1996.0208 ↗
30. 10.1021/la00047a03410.1021/la00047a034 ↗
31. 10.1038/nnano.2010.510.1038/nnano.2010.5 ↗
32. 10.1021/ja901407j10.1021/ja901407j ↗
33. 10.1021/nl202066c10.1021/nl202066c ↗
34. Purchased from Invitrogen (Qdot 605 Streptavidin conjugate).
35. 10.1039/c1nr10181a10.1039/c1nr10181a ↗
36. Israelachvili J. N. · 1991
37. Chignell C. K. · J. Biol. Chem. · 1975 · 250 · 562210.1016/S0021-9258(19)41225-8 ↗
38. 10.1529/biophysj.105.06952610.1529/biophysj.105.069526 ↗
39. Purchased from Nanosensors.